Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2006
Exploiting network biology to improve drug discoveryMarnie L MacDonald, John K WestwickMethods (San Diego, Calif.)|October 31, 2006
Chemical genetic strategies to delineate MAP kinase signaling pathways using protein-fragment complementation assays (PCA)Stephen W Michnick, Marnie L MacDonald, John K WestwickNature Chemical Biology|May 9, 2006
Identifying off-target effects and hidden phenotypes of drugs in human cellsMarnie L MacDonald, Jane Lamerdin, Stephen Owens, et al.Methods in Enzymology|June 8, 2006
Protein-fragment complementation assays (PCA) in small GTPase research and drug discoveryJohn K Westwick, Stephen W MichnickMethods in Molecular Biology (Clifton, N.J.)|August 27, 2011
Improving drug discovery with contextual assays and cellular systems analysisJohn K Westwick, Jane E LamerdinExpert Opinion on Biological Therapy|August 13, 2002
Therapeutic modulation of inflammatory gene transcription by kinase inhibitorsGordon Alton, Klaus Schwamborn, Yoshi Satoh, et al.The Journal of Biological Chemistry|January 14, 2005
SMAD and p38 MAPK signaling pathways independently regulate alpha1(I) collagen gene expression in unstimulated and transforming growth factor-beta-stimulated hepatic stellate cellsShigeki Tsukada, John K Westwick, Kenichi Ikejima, et al.The Journal of Biological Chemistry|June 26, 2002
Raf-independent deregulation of p38 and JNK mitogen-activated protein kinases are critical for Ras transformationKevin Pruitt, Wendy M Pruitt, Graham K Bilter, et al.Assay and Drug Development Technologies|April 20, 2004
Measuring drug action in the cellular context using protein-fragment complementation assaysHelen Yu, Mary West, Brigitte H Keon, et al.Journal of Hepatology|May 12, 2005
JNK mediates hepatic ischemia reperfusion injuryTetsuya Uehara, Brydon Bennett, Steve T Sakata, et al.Pageof 2